▲ SIGMATERMINAL Open Terminal →

Analyses / CRM

CRM Salesforce Inc As of Sep 15, 2026
$259.43

Large-cap SaaS leader up 4.7% intraday; positioned in agentic AI adoption wave. Valuation elevated; earnings growth strong but decelerating.

Setup: Growth + Momentum Confidence: 72 Horizon: 3-6 months Risk: Moderate-High Category: Large Cap
🔒 Trade Plan — entry · target · stop
Entry Zone
$•••–•••
Target
$•••
Stop Loss
$•••
Risk / Reward
•.• : 1
Unlock the exact levels — free →

A free account reveals CRM's entry zone, price target & stop loss. Full 1-week to 1-year price forecasts are included with Pro.

The Thesis

▲ Bull Case

Strong gross margin (77.7%) and operating leverage (18.9% op margin). EPS growth 234% LTM shows earnings acceleration. AI-powered partner tools gaining traction; Europe Green IT market growth tailwind into 2031. Fresh 52-week momentum; insider buying outpace selling 2.04x.

▼ Bear Case

Forward P/E 28.1x and EV/EBITDA 31.8x signal stretched valuation vs. 9.8% revenue growth. Current ratio 0.76 implies near-term working capital tightness. Net margin 18% growing slower than valuation multiples justify. Historical insider selling (413 vs 166 buys) raises lock-in/profit-taking questions.

Valuation

Elevated; growth does not fully support multiples — score 42/100

P/E 21.7x and forward P/E 28.1x sit at or above long-term SaaS median (18–22x). EV/EBITDA 31.8x reflects earnings leverage but signals limited discount to market. P/S 5.05x and price-to-FCF 14.6x in the upper half of cloud cohort range. Growth deceleration risk (9.8% rev CAGR vs. historical 14.3% 5Y) argues for multiple compression if guidance misses.

Technical Levels

Support · $251.50 (Today's Low (intraday)) · $247.72 (Prior Close) · $235.00 (Stop Loss (8.2% below current)) · $146.32 (52-Week Low)

Resistance · $269.11 (52-Week High) · $265.00 (Psychology (intraday range top)) · $285.00 (Target (3m scenario))

RSI: Not provided

Financial Health

Score 68/100. Working capital ratios (current 0.76, quick 0.70) below 1.0 suggests potential near-term liquidity strain if revenue declines sharply or payables spike. However, SaaS businesses typically operate with negative working capital (customer prepayments fund ops). Monitor Q-on-Q cash balance trend. Profitability metrics (op margin, gross margin) robust; interest coverage and debt detail unavailable. Market cap 213.5B and enterprise value 240.8B indicate strong access to capital markets.

Catalysts

Q4 FY2025 Earnings (late Jan/Feb)~4–6 weeksHigh. Guidance for FY2026 revenue growth & margins will re-set market expectations. AI product adoption metrics (agentic workflows, partner tool usage) key. Beat/miss could swing stock ±5–10%.
Salesforce World Tour / Partner SummitSpring 2025Medium. Customer wins & partner ecosystem announcements validate AI roadmap. Could drive retail/institutional rotation into CRM if momentum narrative stays intact.
European Green IT Market Expansion2025–2026Medium. Tailwind market growth (6.9B→14.5B by 2031) to benefit CRM & SAP. Deals, partnerships, or customer wins in EU sustainability software could accelerate revenue.
Macro / Rate Environment ShiftOngoingHigh. If rates fall, multiple expansion likely; if they rise, high P/E stocks like CRM retrace. Monitor Fed policy & yield curve inversion for re-rating risk.

Risk Flags

Forward P/E 28x vs. historical SaaS median ~20x; re-rating risk if growth decelerates or rates rise.
Current & quick ratios (0.76 / 0.70) below healthy threshold; monitor Q-over-Q cash trends.
EPS growth 234% LTM is non-recurring (likely earnings-loss normalization); forward guidance matters.
Insider selling 413 transactions vs. 166 buys suggests some lock-in/diversification by insiders.
RSI, sentiment, fundamentals (balance sheet, cash flow detail) unavailable from provider; recommend cross-check.

See CRM's full trade plan — free

Create a free account to unlock the exact entry, target, and stop — plus run live analysis on any of 5,000+ tickers. No card required.

Unlock CRM free →

Recent News

More Analyses

CRM FAQ

Is CRM a buy right now?

Salesforce Inc's current read is a Growth + Momentum setup with 72 confidence over a 3-6 months horizon. Valuation: Elevated; growth does not fully support multiples. See the full bull and bear case above, or run a live analysis for the exact entry, target and stop.

Is CRM overvalued?

Elevated; growth does not fully support multiples (valuation score 42/100). P/E 21.7x and forward P/E 28.1x sit at or above long-term SaaS median (18–22x). EV/EBITDA 31.8x reflects earnings leverage but signals limited discount to market. P/S 5.05x and price-to-FCF 14.6x in the upper half of cloud cohort range. Growth deceleration risk (9.8% rev CAGR vs. historical 14.3% 5Y) argues for multiple compression if guidance misses.

What are the risks of buying CRM?

Forward P/E 28.1x and EV/EBITDA 31.8x signal stretched valuation vs. 9.8% revenue growth. Current ratio 0.76 implies near-term working capital tightness. Net margin 18% growing slower than valuation multiples justify. Historical insider selling (413 vs 166 buys) raises lock-in/profit-taking questions.